N-PORT filing recap · July 2022

What did ARK Genomic Revolution ETF buy in July 2022?

Reported stock-position changes between this filing and the previous one. These are ARK Genomic Revolution ETF's own holdings, not the firm's.

Stock value

$2.77B

Positions

Estimated turnover

18.8%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

GHGuardant Health, Inc.$28.28Mreported value+563.8K shares MRNAModerna, Inc.$27.90Mreported value+170.0K shares SNTISenti Biosciences Holdings, Inc.$6.79Mreported value+2.17M shares

Increased positions

EXASExact Sciences Corporation$210.25Mreported value+326.4K shares+7.5%TWSTTwist Bioscience Corporation$113.95Mreported value+402.1K shares+18.2%SDGRSchrodinger, Inc.$107.42Mreported value+709.4K shares+26.1%CDNACaredx, Inc.$104.44Mreported value+1.02M shares

Reduced positions

IONSIonis Pharmaceuticals, Inc.$144.99Mreported value-2.07M shares-34.9%TDOCTeladoc Health, Inc.$138.82Mreported value-152.7K shares-3.9%SGFYSignify Health Inc$136.43Mreported value-78.9K shares-1.0%CRSPCrispr Therapeutics AG$130.58Mreported value-147.7K shares

Exited positions

DYNSDynamics Special Purpose Corp.$21.68Mprior reported value-2.19M shares-100.0%BNRBurning Rock Biotech Limited$18.64Mprior reported value-3.38M shares-100.0%EDITEditas Medicine, Inc.$6.69Mprior reported value-505.6K shares-100.0%CSTLCastle Biosciences, Inc.$24.0Kprior reported value